OncoLens Multidisci­plinary
Cancer Treatment Platform

A Connected, Comprehensive Cancer Care
Solution for the Future of Oncology

OncoLens Partners to Fight Pediatric Cancer

We are proud to join MIB Agents in the fight against pediatric osteosarcoma. OncoLens enables MIB’s global TURBO program, providing the infrastructure and platform for research, treatment planning and knowledge sharing on a global scale. Physicians from across the world can now discuss these rare cases with peers and experts, access clinical trials and shared pathways, enabling the best potential treatment plan for their patients.
— Anju Mathew, Founder and CEO, OncoLens
READ MORE

Powering Multidisciplinary Cancer Care

Drive care quality, referrals, and reputation
across your network with OncoLens

40%

increase in referrals
to matching services
across your network

50%

increase in
patient access to multidisciplinary discussions

33%

increase in the number of quality cases discussed per cancer conference

50%

increase in physician and care team engagement

25%

increase in quality review per case

60-90%

time saved in data aggregation and preparation
Improve the complete cancer patient journey with superior communication, analytics, clinical trial matching, and coordination for the entire team.
Access and incorporate everything your patients need from within your network and incorporate expertise or opinions from anywhere in the world.

Delivering One Platform for the
Multidisciplinary Cancer Care Continuum

OncoLens is a single, secure, unified platform that drives multidisciplinary cancer care across the patient journey—from diagnosis to care planning, from care delivery to survivorship. We break down artificial data and technology barriers, enable patient tracking, facilitate provider engagement and referrals, and help cancer programs achieve multidisciplinary care goals.

Empowering Comprehensive Multidisciplinary Care Continuum

Holistic Visibility, Measurability, Usability

Access and action the data you need to maximize MDC care.

Secure (HIPAA) Intra-Enterprise Participation

Engage with experts outside of your network while maintaining compliance and security.

Real-time EMR, Clinical Decision Support Integration

Convert disparate systems into one, simplified and continuously updated patient view.

Next Generation Physician Collaboration

Eliminate artificial communication barriers and consolidate the opinions, insights, and expertise gathered .

Increase / Extend Referral Stream

Inter and intra-network referral visibility across cancer types, therapies, and specialties.

Maximize Clinical Trial Participation

AI-driven clinical trial matching configurable to your program and your patient population.

Capture, Disseminate and Track Quality / Best Practices / Protocols

COC, NAPBC, NAPRC accreditation, adherence to clinical guidelines, and management of facility-level protocols.

Aggregate Data Around the Patient Journey

MDC tracking and reporting that extends from diagnosis through to survivorship.

  • Holistic Visibility, Measurability, Usability

    Access and action the data you need to maximize MDC care.

  • Secure (HIPAA) Intra-Enterprise Participation

    Engage with experts outside of your network while maintaining compliance and security.

  • Real-time EMR, Clinical Decision Support Integration

    Convert disparate systems into one, simplified and continuously updated patient view.

  • Next Generation Physician Collaboration

    Eliminate artificial communication barriers and consolidate the opinions, insights, and expertise gathered .

  • Increase / Extend Referral Stream

    Inter and intra-network referral visibility across cancer types, therapies, and specialties.

  • Maximize Clinical Trial Participation

    AI-driven clinical trial matching configurable to your program and your patient population.

  • Capture, Disseminate and Track Quality / Best Practices / Protocols

    COC, NAPBC, NAPRC accreditation, adherence to clinical guidelines, and management of facility-level protocols.

  • Aggregate Data Around the Patient Journey

    MDC tracking and reporting that extends from diagnosis through to survivorship.
Empowering Comprehensive Multidisciplinary Care Continuum

Collaboration to Drive Access, Consistency, and Quality

OncoLens is built to realize the cancer care you envision—where providers across the network can access unique therapies,
quality of care is consistent regardless of location, and communication, tracking, and reporting are simplified.
With OncoLens, centers can:
Ensure the same care pathways are discussed across all teams and locations
Boost referrals to bone marrow transplant, CAR-T, other services, and sub-specialists
Facilitate accreditations with standardized reporting including CoC, NAPBC, and NAPRC
Measure, track, and market high quality, standardized care across all locations such as time to treatment initiation
Increase clinical trials referrals from the network
Enable education and traction toward molecular based diagnostic and treatment options

  • A Comprehensive, Enriched, Shared Patient View

    OncoLens delivers a single, comprehensive view of the cancer patient that clinicians can understand and action from across disciplines.

    OncoLens uses advanced natural language processing to aggregate data from across EMR, pathology and radiology systems, converting into structured, relevant data to enable better decision making. Providers who use OncoLens have realized an up to 90% increase in multidisciplinary cancer care team efficiency and coordination and a 33% increase in the number of cases discussed per session.

  • Intra-Enterprise, Community, Network and Affiliate Engagement

    OncoLens facilitates next-generation communication and collaboration capabilities so that clinicians can connect synchronously and asynchronously to support decision-making and research.

    Collaboration may be in the form of scheduled meetings such as tumor boards or stat-clinics as well as asynchronous events for a second opinion or peer-to-peer consult. Providers who use OncoLens have realized a 50% increase in physician engagement. This extends beyond a facility or a network to secure, real-time collaboration on patient cases outside your health system.

  • Referral Expansion and Reputation Enhancement

    OncoLens facilitates in-network, cross-network, and targeted therapy/treatment-specific referrals.

    Cancer centers can hardwire the relationship between central and affiliate sites through the platform to increase referrals by up to 40% within the first year.

    As cancer centers compete for more patient share, reputation has become essential to ensuring revenue. With OncoLens, cancer centers can increase patient access to multidisciplinary care by more than 50% within the first year. OncoLens helps support the maturity of a cancer center to a center of excellence (geographic, cancer type, procedural). We do this by enabling accreditation, simplifying and streaming reporting and quality measurements, and facilitating the tracking and sharing of best practices and protocols.

  • Patient Loyalty and Long-term Value

    At OncoLens, we know that care coordination is a crucial driver to patient satisfaction.

    Effective communication and cooperation across a multidisciplinary team of providers and the delivery of services in a timely, complimentary way positively impact patient perception. OncoLens enables a pathway to coordinated care that incorporates the patient and helps translate the value of a multidisciplinary cancer care approach to patient engagement and loyalty. At critical steps within the cancer planning and delivery process, OncoLens helps reduce patient leakage and leverages AI-driven technology to ensure that patients are matched to available treatment options within the network. And patient loyalty is improved through survivorship using OncoLens’ fully integrated survivorship planning capabilities.

A Comprehensive, Enriched, Shared Patient View

OncoLens delivers a single, comprehensive view of the cancer patient that clinicians can understand and action from across disciplines.

OncoLens uses advanced natural language processing to aggregate data from across EMR, pathology and radiology systems, converting into structured, relevant data to enable better decision making. Providers who use OncoLens have realized an up to 90% increase in multidisciplinary cancer care team efficiency and coordination and a 33% increase in the number of cases discussed per session.

Intra-Enterprise, Community, Network and Affiliate Engagement

OncoLens facilitates next-generation communication and collaboration capabilities so that clinicians can connect synchronously and asynchronously to support decision-making and research.

Collaboration may be in the form of scheduled meetings such as tumor boards or stat-clinics as well as asynchronous events for a second opinion or peer-to-peer consult. Providers who use OncoLens have realized a 50% increase in physician engagement. This extends beyond a facility or a network to secure, real-time collaboration on patient cases outside your health system.

Referral Expansion and Reputation Enhancement

OncoLens facilitates in-network, cross-network, and targeted therapy/treatment-specific referrals.

Cancer centers can hardwire the relationship between central and affiliate sites through the platform to increase referrals by up to 40% within the first year.

As cancer centers compete for more patient share, reputation has become essential to ensuring revenue. With OncoLens, cancer centers can increase patient access to multidisciplinary care by more than 50% within the first year. OncoLens helps support the maturity of a cancer center to a center of excellence (geographic, cancer type, procedural). We do this by enabling accreditation, simplifying and streaming reporting and quality measurements, and facilitating the tracking and sharing of best practices and protocols.

Patient Loyalty and Long-term Value

At OncoLens, we know that care coordination is a crucial driver to patient satisfaction.

Effective communication and cooperation across a multidisciplinary team of providers and the delivery of services in a timely, complimentary way positively impact patient perception. OncoLens enables a pathway to coordinated care that incorporates the patient and helps translate the value of a multidisciplinary cancer care approach to patient engagement and loyalty. At critical steps within the cancer planning and delivery process, OncoLens helps reduce patient leakage and leverages AI-driven technology to ensure that patients are matched to available treatment options within the network. And patient loyalty is improved through survivorship using OncoLens’ fully integrated survivorship planning capabilities.

This system of 3,000 analytic cases, increased their average referral by 40%,
realizing an extra $1.5M in net annual revenue.

Driving Multidisciplinary Cancer Quality
from Diagnosis to Survivorship

Multidisciplinary cancer care relies on different perspectives—clinical perspectives, the patient perspective, the oncology community perspective. Bringing these into focus requires an approach beyond a single tumor board, cancer conference, or multidisciplinary team meeting.
OncoLens amplifies complex decisions and care planning so that the multidisciplinary approach’s value reaches from diagnosis to survivorship. We deliver the multidisciplinary cancer care platform that powers tumor boards, case planning, team integration, clinical trial referrals, and quality assessments. With OncoLens, cancer centers have a complete solution that tracks multidisciplinary team performance irrespective of EMRs, geographies, and practice boundaries.
We envision a world where every cancer patient has access to the best possible minds, therapies, and innovations in care—in time to make a difference.
We envision a world where every cancer patient has access to the best possible minds, therapies, and innovations in care—in time to make a difference.

Improving the Cancer Patient Journey—Improving Outcomes

At the center of multidisciplinary cancer care is the patient. A multidisciplinary approach leads to
higher patient satisfaction, compliance with care plans, and loyalty when done well.
The cancer patient’s journey depends—in large part—on trust: trust in the provider, trust in the plan, trust in the treatment, and trust in the process. Patient trust is maintained and managed through communication and assurance of multidisciplinary inputs. When a patient knows that a team of specialists and experts are informing the care plan, she is more likely to adhere to the care pathway, remain loyal to the provider, and have a higher level of satisfaction.
OncoLens incorporates the patient into every aspect of care planning, communication, and delivery.
As a result, oncology programs can:
  • Lower rates of avoidable deterioration and ED utilization
  • Improve patient engagement
  • Improve patient satisfaction
  • Increase patient resilience to potential changes in a care pathway
  • Increase patient loyalty to a provider and the network
  • Increase patient-led referrals

Frequently Asked Questions

Why is a multidisciplinary approach important to the future of cancer care?

Cancer is complicated, and so is cancer treatment. The Institute of Medicine recommends a patient-centered, team-based model of care for cancer patients. This is where multidisciplinary cancer (MDC) care comes in. The team approach brings together experts from across disciplines to discuss a patient case, define a care path, and share the latest research and treatments available. But the operationalization of an MDC care approach is challenging. Barriers to data sharing, provider communication and collaboration, and patient visibility have limited the adoption of an MDC approach despite its proven positive impact on patient lives. OncoLens is the first comprehensive cancer care platform designed around multidisciplinary care. The solution amplifies complex decisions and care planning so that the value of the MDC approach reaches from diagnosis through to survivorship.

What is a Tumor Board?
According to the American Society of Clinical Oncologists (ASCO), a Tumor Board is “a group of doctors and other health care providers with different specialties that meets regularly at the hospital to discuss cancer cases and share knowledge.” Sometimes referred to as a cancer conference, Tumor Boards serve as a structured opportunity for multiple clinicians, including pathologists, surgeons, clinical oncologists, and radiologists, to discuss a patient case. In addition to supporting multidisciplinary care goals, Tumor Boards also educate providers, serve as an opportunity to share best practices, and identify new treatment options including clinical trials.
What is a Molecular Tumor Board?
A Molecular Tumor Board (MTB) is a type of tumor board that includes discussion and review of a patient’s genomic and genetic profile. It is typically part of a precision medicine approach that combines genomic data and clinical attributes to create a personalized treatment plan. Many times, a patient referred to an MTB has a complex type of cancer or a cancer that was unresponsive to standard treatment. Understanding and actioning genetic alterations is complex and challenging. Therapies, guidelines, available clinical trials, and our understanding of how alterations contribute to cancer and responsiveness to particular drugs constantly changes. OncoLens helps reduce this complexity by facilitating MTBs and incorporating the latest thinking in precision medicine including benchmarks from COSMIC and other databases directly into the staging and biomarker discussion.
What does MDT stand for?

MDT stands for multidisciplinary team. MDTs help coordinate cancer care and organize experts from across disciplines to assess, plan, and manage a patient’s cancer care journey. 

How does OncoLens drive standardization and efficiency across Tumor Boards?
OncoLens supports Tumor Boards by integrating data from multiple sources across the care continuum. The solution reduces the labor-intensive, manual processes that drive provider burnout and limit the number of patients discussed within the Tumor Board setting. OncoLens ensures that participating clinicians, regardless of their facility or network, have the documentation they need, converting unstructured data to structured, usable data and providing the ability to communicate and collaborate with their peers. As a result, providers who leverage OncoLens have realized an up to 44 percent increase in the number of cases reviewed at Tumor Boards and increased clinical trial accrual across disease sites.
What makes OncoLens different from Tumor Board solutions or virtual meeting platforms?
OncoLens goes beyond the Tumor Board to bring the expertise and insights documented and actioned as part of the Tumor Board through to every aspect of cancer care, including survivorship. Data is streamlined and updated as new insights are uncovered. Protocols and best practices are shared across providers, the network, and the broader oncology community. Providers have realized up to a 90% increase in multidisciplinary cancer care team efficiency and coordination. And OncoLens eliminates the artificial data and location barriers that limit engagement, lower referrals, and impact patient care. While OncoLens brings virtualization natively into the multidisciplinary cancer care workflow, that is just one part of our solution functionality. It is something that a provider can choose to use if it makes sense for the program. OncoLens isn’t about virtualization—we are about true multidisciplinary cancer care that leads to better health, greater knowledge sharing, and decision making.
Why would I use OncoLens instead of my EMR’s (Epic, Cerner, etc.) tumor board functionality?
Some EMRs are building tumor board meeting facilitation capabilities into their solutions. While these forms may help to organize and capture data, they cannot enable or facilitate multidisciplinary decision making. EMRs do not provide a longitudinal view of the cancer patient and the patient journey; and EMRs are not tied to cancer quality, leading cancer practices, and accreditation standards. EMRs are fundamentally billing systems. OncoLens integrates with EMRs to capture and make use of patient information collected within the EMR and transforms this data into inputs that support multidisciplinary cancer care, tracking of quality, adherence to care pathways.
How does OncoLens improve visibility into clinical trials and treatment options?
OncoLens brings clinical trials directly into the workflow and ensures that providers have visibly into the options that are a fit for a specific patient. Leveraging AI capabilities, the platform helps narrow the number of clinical trials presented based on the patient, cancer type, location, and timing. This helps to focus the team on the clinical trials that are most relevant for a specific patient case.
What do Cancer Registrars and Certified Tumor Registrars say about OncoLens?
OncoLens reduces unnecessary administrative and duplicative work and streamlines the process from prep to delivery and reporting for Cancer Registrars (CRs) and Certified Tumor Registrars (CTRs). The intelligent, rules-based workflow embedded within the solution ensures that all necessary information is available for rapid review. As care plans are discussed, accreditation and reporting requirements are documented—making the entire process more efficient. CRs and CTRs report up to a 90% decrease in administrative, non-value-added tasks, thereby freeing their time to drive strategic value for their cancer program.
How does OncoLens support CME tracking and reporting for my Tumor Boards?
OncoLens simplifies the CME process by tracking attendance, auto-creating CME flyers, and producing the attendance reports required by your accrediting organizations. Reporting is multi-level so that you can see your CME progress and status at the organizational, event, and provider levels.
How does OncoLens support accreditation?
OncoLens continuously monitors accreditation standards including the Commission on Cancer (CoC), National Accreditation Program for Breast Centers (NAPBC) and National Accreditation Program for Rectal Cancer (NAPRC). The platform incorporates the quality metrics necessary in each relevant case discussion. Reports customized to the specific needs of the accrediting bodies can then be downloaded at any point of time, eliminating the workload needed to track, collate, and build reports manually.
What are the OncoLens EMR integration options?
OncoLens has established scripts and data formats for the major ONC Certified EMRs, including EPIC, Cerner, OncoEMR, athenahealth, Mosaiq, ARIA and more. We eliminate many of the challenges created by EMRs and enhance the EMR experience by consolidating data, eliminating dual entry, finding and extracting critical information through natural language processing, and creating a longitudinal view of the patient that can be shared across clinical team members on multiple EMRs across multiple networks.
Does OncoLens integrate with my cancer registry software?
OncoLens delivers seamless integration into the cancer registry software to accelerate the identification and intake of new cancer cases for abstracting. Data collected by OncoLens can be imported directly at any time—immediately after each Tumor Board or Cancer Conference, at set intervals, in batches based on tumor type—based on your workflow.
What kind of security options does OncoLens provide?
OncoLens is fully HIPAA compliant and includes advanced security options such as single sign on (SSO) to drive better security, ease of use, and flexibility.

Ready to Learn More?

Want to learn more about OncoLens solutions? Reach out to us and schedule a demo. See how OncoLens can bring multidisciplinary cancer care into focus.